Implications of observation-fact modifiers to i2b2 ontologies by London, Jack W. & Chatterjee, Devjani
Thomas Jefferson University
Jefferson Digital Commons
Faculty papers Kimmel Cancer Center Kimmel Cancer Center
11-12-2011
Implications of observation-fact modifiers to i2b2
ontologies
Jack W. London
Kimmel Cancer Center, Thomas Jefferson University, Jack.London@jefferson.edu
Devjani Chatterjee
Kimmel Cancer Center, Thomas Jefferson University, Devjani.Chatterjee@jefferson.edu
Let us know how access to this document benefits you
Follow this and additional works at: http://jdc.jefferson.edu/kimmelccfp
Part of the Oncology Commons
This Article is brought to you for free and open access by the Jefferson Digital Commons. The Jefferson Digital Commons is a service of Thomas
Jefferson University's Center for Teaching and Learning (CTL). The Commons is a showcase for Jefferson books and journals, peer-reviewed scholarly
publications, unique historical collections from the University archives, and teaching tools. The Jefferson Digital Commons allows researchers and
interested readers anywhere in the world to learn about and keep up to date with Jefferson scholarship. This article has been accepted for inclusion in
Faculty papers Kimmel Cancer Center by an authorized administrator of the Jefferson Digital Commons. For more information, please contact:
JeffersonDigitalCommons@jefferson.edu.
Recommended Citation
London, Jack W. and Chatterjee, Devjani, "Implications of observation-fact modifiers to i2b2
ontologies" (2011). Faculty papers Kimmel Cancer Center. Paper 15.
http://jdc.jefferson.edu/kimmelccfp/15
As submitted to: 
2011 IEEE International Conference on Bioinformatics and Biomedicine 
Workshops (BIBMW). 
12-15 November 2011, Pages 929-930 
10.1109/BIBMW.2011.6112507  
 
London, J. W., & Chatterjee, D. (2011). Implications of observation-fact modifiers to i2b2 
ontologies. 2011 IEEE International Conference on Bioinformatics and Biomedicine Workshops 
(BIBMW), 12-15 November, 929-930.
Implications of Observation-Fact Modifiers to i2b2 Ontologies 
 
 
Jack W. London, PhD and Devjani Chatterjee, PhD 
Kimmel Cancer Center, Thomas Jefferson University, Philadelphia PA 
jack.london@KimmelCancerCenter.org 
 
 
Abstract 
Biomedical translational research can be facilitated 
by integrating clinical and research data. In 
particular, study cohort identification and hypothesis 
generation is enabled by the mining of integrated 
clinical observations and research resources.  The 
“informatics for integrating biology and the bedside,” 
or i2b2,  framework is widely used for this biomedical 
data mining.  The i2b2 “star schema” data model 
using entity-attribute-value (EAV) formatted concepts 
is a very efficient strategy for querying large amounts 
of data.  However, until the most recent i2b2 release, 
the utility of the platform was somewhat constrained by 
the limitations on being able to express “facts about 
facts” – i.e., modify the observations about the 
patients.  We have found that exploiting the new 
modifier functionality has significantly and favorably 
impacted the design of i2b2 ontologies, leading to 
easier and more meaningful query results. 
 
Introduction 
Research data marts are sources of clinical and 
research data on individuals for investigators.  Clinical 
data including demographics, diagnoses, laboratory 
values, medications, procedures, and outcomes, can be 
extracted from clinical systems, transformed, and 
loaded into a clinical data warehouse (CDW).  This 
CDW can in turn populate a research data mart (RDM) 
with a de-identified set of these data, in which HIPAA-
defined Personal Health Information has been 
removed.  Clinical data in the RDM can be augmented 
with research information, including annotation 
describing biospecimens available to researchers, 
clinical trial information, and registry data. 
At Thomas Jefferson University we have deployed 
the i2b2 framework [1] to provide investigators with a 
simple to use query tool for cohort identification and 
hypothesis generation.  Hospital clinical data 
(including demographics, diagnoses, procedures, 
medications, and laboratory results) were integrated 
with research biorepository annotation and cancer 
tumor registry data in a de-identified RDM [2].  We 
created ontologies for both the biospecimen and 
registry data. (caTissue, the NCI’s cancer Biomedical 
Informatics Grid (caBIG®) biorepository management 
tool is used for research biobanking at TJU.)   The 
ontologies we developed were constrained by the data 
model’s ability to easily express facts about patients, 
but not readily express facts about facts.  For example, 
the observation that an individual had banked colon 
tissue could be straightforwardly represented, but 
adding other modifiers, such as that the tissue was 
frozen and malignant, was only possible by 
constructing redundant ontologies. 
Release 1.6 of i2b2 has utilized an extension to the 
basic star schema model that allows for modifiers to be 
directly employed in the observation-fact dimension.  
This has allowed us to simplify the ontologies we use, 
particularly those for biospecimen annotation and 
registry data. 
 
Methods 
The biospecimen and cancer registry ontologies that 
we developed for our initial deployment of the i2b2 
web-based query application (version 1.5) were 
redesigned to utilize the modifier functionality 
available with i2b2 release 1.6.  The extraction-
transform-load software procedures that moved the 
data from their sources (caTissue and Metriq) to the 
i2b2 database were modified to support the new 
ontologies.  User training was updated to use these new 
query strategies. 
 
Conclusion 
The ability to directly represent observation-fact 
modifiers has significantly enhanced the investigators’ 
query capabilities, allowing them to more specifically 
describe the attributes they are seeking, while 
navigating a simpler ontology classification scheme.  
Of great consequence also is the ability to now include 
a HIPAA-compliant specimen identifier to the i2b2 
specimen annotation, providing a means for an honest 
broker to easily order the material identified by the 
researcher’s query.  The value of RDMs is greatly 
enhanced by observation-fact modifiers. 
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